{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:42:06Z","timestamp":1790347326927,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This review examines the evolving role of catheter\u2010based valvular and structural interventions in cancer patients. We sought to answer whether minimally invasive approaches, including transcatheter aortic valve replacement, mitral valve repair, left atrial appendage occlusion, and patent foramen ovale closure, provide safe and effective treatments in high\u2010risk oncologic populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Emerging research indicates that these interventions yield comparable short\u2010term outcomes in cancer and non\u2010cancer patients, with reduced procedural complications, lower bleeding risks, and improved recovery times. Studies also suggest that careful patient selection and tailored antithrombotic management are critical, as long\u2010term survival is affected by the underlying malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Our review concludes that catheter\u2010based interventions offer significant benefits in managing cardiovascular complications in cancer patients. Future investigations should focus on refining selection criteria, optimizing perioperative care, and evaluating long\u2010term outcomes to enhance interdisciplinary treatment strategies. These findings pave the way for improved care via a tailored approach to patients with both cancer and cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-026-02351-x","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:32:55Z","timestamp":1772598775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Catheter-Based Valvular and Structural Interventions in Cancer Patients"],"prefix":"10.1007","volume":"28","author":[{"given":"Tony","family":"Joudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neehal","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochell","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoha","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok A.","family":"Khorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezar","family":"Illescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Moudgil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"4","key":"2351_CR1","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","volume":"77","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):e25\u2013197.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2351_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1912846","volume":"382","author":"D-H Kang","year":"2020","unstructured":"Kang D-H, Park S-J, Lee S-A, Lee S, Kim D-H, Kim H-K, et al. Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. N Engl J Med. 2020;382(2):111\u20139.","journal-title":"N Engl J Med"},{"issue":"9986","key":"2351_CR3","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","volume":"385","author":"SR Kapadia","year":"2015","unstructured":"Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485\u201391.","journal-title":"Lancet"},{"issue":"36","key":"2351_CR4","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768\u2013801.","journal-title":"Eur Heart J"},{"issue":"1","key":"2351_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jcin.2018.10.026","volume":"12","author":"U Landes","year":"2019","unstructured":"Landes U, Iakobishvili Z, Vronsky D, Zusman O, Barsheshet A, Jaffe R, et al. Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis. JACC Cardiovasc Interv. 2019;12(1):78\u201386.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"2351_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ahj.2011.03.013","volume":"161","author":"SW Yusuf","year":"2011","unstructured":"Yusuf SW, Sarfaraz A, Durand JB, Swafford J, Daher IN. Management and outcomes of severe aortic stenosis in cancer patients. Am Heart J. 2011;161(6):1125\u201332.","journal-title":"Am Heart J"},{"issue":"1","key":"2351_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0145-2126(98)00126-X","volume":"23","author":"LE Samuels","year":"1999","unstructured":"Samuels LE, Kaufman MS, Morris RJ, Styler M, Brockman SK. Open heart surgery in patients with chronic lymphocytic leukemia. Leuk Res. 1999;23(1):71\u20135.","journal-title":"Leuk Res"},{"key":"2351_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.carrev.2020.08.018","volume":"23","author":"AN Kadri","year":"2021","unstructured":"Kadri AN, Bernardo M, Assar SZ, Werns S, Abbas AE. Surgical versus transcatheter aortic valve replacement in patients with malignancy. Cardiovasc Revasc Med. 2021;23:59\u201365.","journal-title":"Cardiovasc Revasc Med"},{"issue":"11","key":"2351_CR9","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jacc.2013.10.058","volume":"63","author":"P G\u00e9n\u00e9reux","year":"2014","unstructured":"G\u00e9n\u00e9reux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014;63(11):1100\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2351_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014248","volume":"9","author":"A Guha","year":"2020","unstructured":"Guha A, Dey AK, Arora S, Cavender MA, Vavalle JP, Sabik JF III, et al. Contemporary trends and outcomes of percutaneous and surgical aortic valve replacement in patients with cancer. J Am Heart Assoc. 2020;9(2):e014248.","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"2351_CR11","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","volume":"370","author":"DH Adams","year":"2014","unstructured":"Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis. N Engl J Med. 2014;370(19):1790\u20138.","journal-title":"N Engl J Med"},{"issue":"17","key":"2351_CR12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597\u2013607.","journal-title":"N Engl J Med"},{"issue":"9","key":"2351_CR13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.amjcard.2020.01.047","volume":"125","author":"A Guha","year":"2020","unstructured":"Guha A, Dey AK, Omer S, Abraham WT, Attizzani G, Jneid H, et al. Contemporary trends and outcomes of percutaneous and surgical mitral valve replacement or repair in patients with cancer. Am J Cardiol. 2020;125(9):1355\u201360. https:\/\/doi.org\/10.1016\/j.amjcard.2020.01.047.","journal-title":"Am J Cardiol"},{"issue":"23","key":"2351_CR14","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"CR Smith","year":"2011","unstructured":"Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187\u201398.","journal-title":"N Engl J Med"},{"issue":"18","key":"2351_CR15","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa1114705","volume":"366","author":"M Gilard","year":"2012","unstructured":"Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705\u201315.","journal-title":"N Engl J Med"},{"key":"2351_CR16","doi-asserted-by":"publisher","first-page":"641268","DOI":"10.3389\/fcvm.2021.641268","volume":"8","author":"K Marmagkiolis","year":"2021","unstructured":"Marmagkiolis K, Monlezun DJ, Cilingiroglu M, Grines C, Herrmann J, Toutouzas KP, et al. TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-Regression. Front Cardiovasc Med. 2021;8:641268.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"2351_CR17","first-page":"e73442","volume":"16","author":"U Ahsan","year":"2024","unstructured":"Ahsan U, Naz S, Anum A, Unum A, Hamza RM, Qasim RM, et al. Outcomes and Adverse Effects of Transcatheter Aortic Valve Replacement (TAVR) in Cancer Patients: A Meta-Analysis. Cureus. 2024;16(11):e73442.","journal-title":"Cureus"},{"key":"2351_CR18","doi-asserted-by":"publisher","unstructured":"Ullah W, Thalambedu N, Zahid S et al. Trends and Outcomes of TAVI and SAVR in Cancer and Noncancer Patients: A Nationwide Analysis. JACC Adv. 2023;2 (1) https:\/\/doi.org\/10.1016\/j.jacadv.2022.100167","DOI":"10.1016\/j.jacadv.2022.100167"},{"key":"2351_CR19","doi-asserted-by":"publisher","unstructured":"Faggiano P, Lorusso R, Carugo S. et al. Heart Valve Team Conundrum: The Optimal Management Strategy of Severe Aortic Stenosis in Cancer Patients\u2217 . JACC Adv. 2023;2 (1). https:\/\/doi.org\/10.1016\/j.jacadv.2022.100190","DOI":"10.1016\/j.jacadv.2022.100190"},{"issue":"21","key":"2351_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030072","volume":"12","author":"T Aikawa","year":"2023","unstructured":"Aikawa T, Kuno T, Malik AH, Briasoulis A, Kolte D, Kampaktsis PN, et al. Transcatheter aortic valve replacement in patients with or without active cancer. J Am Heart Assoc. 2023;12(21):e030072.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2351_CR21","first-page":"506","volume":"2","author":"V Jain","year":"2020","unstructured":"Jain V, Saad AM, Gad MM, Bansal A, Abdelfattah O, Farwati M, et al. Outcomes of cancer patients undergoing transcatheter aortic valve replacement. JACC: CardioOncology. 2020;2(3):506\u20138.","journal-title":"JACC: CardioOncology"},{"key":"2351_CR22","doi-asserted-by":"publisher","unstructured":"\u00d6ner A, et al. Previous malignancy is an independent predictor of follow-up mortality after percutaneous treatment of mitral valve regurgitation by means of MitraClip. Cardiovasc Ther. 2017;35(2). https:\/\/doi.org\/10.1111\/1755-5922.12239.","DOI":"10.1111\/1755-5922.12239"},{"issue":"3","key":"2351_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00392-020-01770-2","volume":"110","author":"N Tabata","year":"2021","unstructured":"Tabata N, et al. Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repair. Clin Res Cardiol. 2021;110(3):440\u201350.","journal-title":"Clin Res Cardiol"},{"issue":"24","key":"2351_CR24","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379(24):2307\u201318.","journal-title":"N Engl J Med"},{"key":"2351_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.amjcard.2022.04.041","volume":"176","author":"A Bansal","year":"2022","unstructured":"Bansal A, et al. Outcomes of patients with cancer who underwent transcatheter mitral valve repair with MitraClip. Am J Cardiol. 2022;176:141\u20133.","journal-title":"Am J Cardiol"},{"issue":"2","key":"2351_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11748-006-0070-x","volume":"55","author":"A Tamura","year":"2007","unstructured":"Tamura A, et al. Radiation-induced valvular disease is the logical consequence of irradiation. Gen Thorac Cardiovasc Surg. 2007;55(2):53\u20136.","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"12","key":"2351_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11886-020-01411-0","volume":"22","author":"S Xu","year":"2020","unstructured":"Xu S, Donnellan E, Desai MY. Radiation-associated valvular disease. Curr Cardiol Rep. 2020;22(12):167.","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"2351_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.amjcard.2018.06.048","volume":"122","author":"S Siddamsetti","year":"2018","unstructured":"Siddamsetti S, Balasubramanian S, Yandrapalli S, Vij A, Joshi U, Tang G, et al. Meta-Analysis Comparing Dual Antiplatelet Therapy Versus Single Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation. Am J Cardiol. 2018;122(8):1401\u20138.","journal-title":"Am J Cardiol"},{"issue":"14","key":"2351_CR29","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/heartjnl-2014-307053","volume":"101","author":"MECJ Hassell","year":"2015","unstructured":"Hassell MECJ, Hildick-Smith D, Durand E, Kikkert WJ, Wiegerinck EMA, Stabile E, et al. Antiplatelet therapy following transcatheter aortic valve implantation. Heart. 2015;101(14):1118\u201325.","journal-title":"Heart"},{"issue":"2","key":"2351_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1634\/theoncologist.2016-0110","volume":"22","author":"A Feher","year":"2017","unstructured":"Feher A, Kampaktsis PN, Parameswaran R, Stein EM, Steingart R, Gupta D. Aspirin is associated with improved survival in severely thrombocytopenic cancer patients with acute myocardial infarction. Oncologist. 2017;22(2):213\u201321.","journal-title":"Oncologist"},{"key":"2351_CR31","doi-asserted-by":"crossref","unstructured":"Wyler von Ballmoos MC et al. The Society of Thoracic Surgeons 2023 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg, 2024;118(2): p. 291\u2013310.","DOI":"10.1016\/j.athoracsur.2024.01.007"},{"issue":"24","key":"2351_CR32","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","volume":"65","author":"DR Holmes Jr","year":"2015","unstructured":"Holmes DR Jr, et al. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. J Am Coll Cardiol. 2015;65(24):2614\u201323.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"2351_CR33","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964\u201375.","journal-title":"J Am Coll Cardiol"},{"key":"2351_CR34","doi-asserted-by":"crossref","unstructured":"Issa R et al. Abstract 4138212: Efficacy of Left Atrial Appendage Occlusion in Reducing Mortality and Major Bleeding Events in Cancer Patients with Atrial Fibrillation. Circulation, 2024;150(Suppl_1): A4138212.","DOI":"10.1161\/circ.150.suppl_1.4138212"},{"key":"2351_CR35","unstructured":"Yee K Lui F. Anatomy, Thorax, Heart Foramen Ovale. [Updated 2023 Jul 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545203\/"},{"issue":"6","key":"2351_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/jcdd8060060.PMID:34070460;PMCID:PMC8228640","volume":"8","author":"V Romano","year":"2021","unstructured":"Romano V, Gallinoro CM, Mottola R, Serio A, Di Meglio F, Castaldo C, et al. Patent Foramen Ovale-A Not So Innocuous Septal Atrial Defect in Adults. J Cardiovasc Dev Dis. 2021;8(6):60. https:\/\/doi.org\/10.3390\/jcdd8060060.PMID:34070460;PMCID:PMC8228640.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"4","key":"2351_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/WNL.0000000000011264","volume":"96","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wang K, Du P, Yang W, He Y, Li T, et al. Risk of stroke in cancer survivors: a meta-analysis of population-based cohort studies. Neurology. 2021;96(4):26-e526. https:\/\/doi.org\/10.1212\/WNL.0000000000011264.","journal-title":"Neurology"},{"issue":"21","key":"2351_CR38","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.3390\/jcm13216354.PMID:39518493;PMCID:PMC11546784","volume":"13","author":"E Kayvanpour","year":"2024","unstructured":"Kayvanpour E, Matzeit E, Kaya Z, Pleger S, Bahrmann A, Reichardt C, et al. Comparative Effectiveness of Devices for Interventional Patent Foramen Ovale Closure: Insights from a 23-Year Monocentric Analysis. J Clin Med. 2024;13(21):6354. https:\/\/doi.org\/10.3390\/jcm13216354.PMID:39518493;PMCID:PMC11546784.","journal-title":"J Clin Med"},{"issue":"10","key":"2351_CR39","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4065\/76.10.1057","volume":"76","author":"VT Nkomo","year":"2001","unstructured":"Nkomo VT, Theuma P, Maniu CV, Chandrasekaran K, Miller FA, Schaff HV, et al. Patent foramen ovale transcatheter closure device thrombosis. Mayo Clin Proc. 2001;76(10):1057\u201361. https:\/\/doi.org\/10.4065\/76.10.1057.","journal-title":"Mayo Clin Proc"},{"issue":"3\u20134","key":"2351_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3121\/cmr.2019.1444","volume":"17","author":"BR Potugari","year":"2019","unstructured":"Potugari BR, et al. Ovarian Cancer Presenting as Cryptogenic Stroke from Patent Foramen Ovale. Clin Med Res. 2019;17(3\u20134):97\u2013101.","journal-title":"Clin Med Res"},{"key":"2351_CR41","doi-asserted-by":"crossref","unstructured":"Steinauer F et al. Abstract TP225: Prevalence of Patent Foramen Ovale in Patients With Cancer-Related Stroke. Stroke, 2024;55(Suppl_1): ATP225.","DOI":"10.1161\/str.55.suppl_1.TP225"},{"issue":"1","key":"2351_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5853\/jos.2019.02278","volume":"22","author":"OY Bang","year":"2020","unstructured":"Bang OY, et al. Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms. J Stroke. 2020;22(1):1\u201310.","journal-title":"J Stroke"},{"issue":"41","key":"2351_CR43","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244.","journal-title":"Eur Heart J"},{"issue":"7","key":"2351_CR44","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1055\/s-0035-1564040","volume":"41","author":"A Falanga","year":"2015","unstructured":"Falanga A, Schieppati F, Russo D. Cancer tissue procoagulant mechanisms and the hypercoagulable state of patients with cancer. Semin Thromb Hemost. 2015;41(7):756\u201364.","journal-title":"Semin Thromb Hemost"},{"issue":"19","key":"2351_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38831","volume":"10","author":"Q Peng","year":"2024","unstructured":"Peng Q, et al. Blood hypercoagulability and thrombosis mechanisms in cancer patients \u2013 a brief review. Heliyon. 2024;10(19):e38831.","journal-title":"Heliyon"},{"key":"2351_CR46","first-page":"101072","volume":"41","author":"B Bungo","year":"2022","unstructured":"Bungo B, et al. Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA2DS2VASC score: CCHA2DS2VASC score. Int J Cardiol Heart Vasc. 2022;41:101072.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2351_CR47","doi-asserted-by":"crossref","unstructured":"Majeed Z et al. Abstract 4144471: Addition of Malignancy into the CHADS2\/CHADS2VASc Score: Better prediction of stroke risk in cancer patients with atrial fibrillation. Circulation, 2024;150(Suppl_1): A4144471.","DOI":"10.1161\/circ.150.suppl_1.4144471"},{"issue":"15","key":"2351_CR48","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(15):4902\u20137. https:\/\/doi.org\/10.1182\/blood-2007-10-116327.","journal-title":"Blood"},{"issue":"6","key":"2351_CR49","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jvsv.2022.05.003","volume":"10","author":"H Hayssen","year":"2022","unstructured":"Hayssen H, Cires-Drouet R, Englum B, Nguyen P, Sahoo S, Mayorga-Carlin M, et al. Systematic review of venous thromboembolism risk categories derived from Caprini score. J Vasc Surg Venous Lymphat Disord. 2022;10(6):1401-1409.e7. https:\/\/doi.org\/10.1016\/j.jvsv.2022.05.003.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"3","key":"2351_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/SVIN.122.000423","volume":"3","author":"F Letteri","year":"2023","unstructured":"Letteri F, Pracucci G, Saia V, et al. Endovascular treatment in patients with acute ischemic stroke and comorbid cancer: analysis of the Italian Registry of Endovascular Treatment in Acute Stroke. Stroke Vasc Interv Neurol. 2023;3(3):e000423. https:\/\/doi.org\/10.1161\/SVIN.122.000423.","journal-title":"Stroke Vasc Interv Neurol"},{"key":"2351_CR51","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/10428190802714024","volume":"50","author":"C Cartoni","year":"2009","unstructured":"Cartoni C, Niscola P, Breccia M, Brunetti G, D\u2019Elia GM, Giovannini M, et al. Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience. Leuk Lymphoma. 2009;50:387\u201391.","journal-title":"Leuk Lymphoma"},{"key":"2351_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-132","volume":"7","author":"N Cihoric","year":"2012","unstructured":"Cihoric N, Crowe S, Eychmuller S, Aebersold DM, Ghadjar P. Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy. Radiat Oncol. 2012;7:132.","journal-title":"Radiat Oncol"},{"key":"2351_CR53","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1634\/theoncologist.9-5-561","volume":"9","author":"J Pereira","year":"2004","unstructured":"Pereira J, Phan T. Management of bleeding in patients with advanced cancer. Oncologist. 2004;9:561\u201370.","journal-title":"Oncologist"},{"key":"2351_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/apm.2017.11.01","volume":"7","author":"C Johnstone","year":"2018","unstructured":"Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Ann Palliat Med. 2018;7:265\u201373.","journal-title":"Ann Palliat Med"},{"key":"2351_CR55","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1111\/j.1538-7836.2006.02082.x","volume":"4","author":"M Monreal","year":"2006","unstructured":"Monreal M, Falga C, Valdes M, Suarez C, Gabriel F, Tolosa C, et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry. J Thromb Haemost. 2006;4:1950\u20136.","journal-title":"J Thromb Haemost"},{"key":"2351_CR56","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, et al. Complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100:3484\u20138.","journal-title":"Blood"},{"key":"2351_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.amjmed.2016.10.017","volume":"130","author":"I Mahe","year":"2017","unstructured":"Mahe I, Chidiac J, Bertoletti L, Font C, Trujillo-Santos J, Peris M, et al. The clinical course of venous thromboembolism may differ according to cancer site. Am J Med. 2017;130:337\u201347.","journal-title":"Am J Med"},{"key":"2351_CR58","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715\u201322.","journal-title":"JAMA"},{"key":"2351_CR59","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/bloodadvances.2019000369","volume":"3","author":"H Al-Samkari","year":"2019","unstructured":"Al-Samkari H, Connors JM. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy. Blood Adv. 2019;3:3770\u20139.","journal-title":"Blood Adv"},{"key":"2351_CR60","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ajh.25494","volume":"94","author":"DE Angelini","year":"2019","unstructured":"Angelini DE, Radivoyevitch T, McCrae KR, Khorana AA. Bleeding incidence and risk factors among cancer patients treated with anticoagulation. Am J Hematol. 2019;94:780\u20135.","journal-title":"Am J Hematol"},{"key":"2351_CR61","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","volume":"36","author":"AM Young","year":"2018","unstructured":"Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, et al. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D). J Clin Oncol. 2018;36:2017\u201323.","journal-title":"J Clin Oncol"},{"key":"2351_CR62","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","volume":"363","author":"R Bauersachs","year":"2010","unstructured":"Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499\u2013510 (Investigators E).","journal-title":"N Engl J Med"},{"key":"2351_CR63","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","volume":"382","author":"G Agnelli","year":"2020","unstructured":"Agnelli G, Becattini C, Meyer G, Munoz A, Huisman MV, Connors JM, et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382:1599\u2013607.","journal-title":"N Engl J Med"},{"key":"2351_CR64","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1302507","volume":"369","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369:799\u2013808 (Investigators A).","journal-title":"N Engl J Med"},{"issue":"4","key":"2351_CR65","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.athoracsur.2013.12.029","volume":"97","author":"MY Desai","year":"2014","unstructured":"Desai MY, Wu W, Masri A, Popovic ZB, Agarwal S, Smedira NG, et al. Increased aorto-mitral curtain thickness independently predicts mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. Ann Thorac Surg. 2014;97(4):1348\u201355.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"2351_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-019-0726-3","volume":"21","author":"E Donnellan","year":"2019","unstructured":"Donnellan E, Jellis CL, Griffin BP. Radiation-associated cardiac disease: from molecular mechanisms to clinical management. Curr Treat Options Cardiovasc Med. 2019;21(5):22.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"11","key":"2351_CR67","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br\u00f8nnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987\u201398.","journal-title":"N Engl J Med"},{"issue":"15","key":"2351_CR68","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.119.040546","volume":"140","author":"E Donnellan","year":"2019","unstructured":"Donnellan E, Alashi A, Johnston DR, Gillinov AM, Pettersson GB, Svensson LG, et al. Outcomes of patients with mediastinal radiation-associated mitral valve disease undergoing cardiac surgery. Circulation. 2019;140(15):1288\u201390.","journal-title":"Circulation"},{"key":"2351_CR69","doi-asserted-by":"crossref","unstructured":"Donnellan E, Masri A, Johnston DR, Pettersson GB, Rodriguez LL, Popovic ZB, et al Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc. 2017;6(5). https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.116.005396.","DOI":"10.1161\/JAHA.116.005396"},{"issue":"16","key":"2351_CR70","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.118.035514","volume":"138","author":"E Donnellan","year":"2018","unstructured":"Donnellan E, Krishnaswamy A, Hutt-Centeno E, Johnston DR, Aguilera J, Kapadia SR, et al. Outcomes of Patients With Mediastinal Radiation-Associated Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. Circulation. 2018;138(16):1752\u20134.","journal-title":"Circulation"},{"key":"2351_CR71","volume":"6","author":"MR Zafar","year":"2020","unstructured":"Zafar MR, Mustafa SF, Miller TW, Alkhawlani T, Sharma UC. Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: a systematic review and meta-analysis. Cardiooncology. 2020;6:8.","journal-title":"Cardiooncology"},{"key":"2351_CR72","doi-asserted-by":"crossref","unstructured":"Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, et al. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(8):851\u201380.","DOI":"10.6004\/jnccn.2023.0040"},{"issue":"4","key":"2351_CR73","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/heartjnl-2015-308765","volume":"102","author":"DM Gujral","year":"2016","unstructured":"Gujral DM, Lloyd G, Bhattacharyya S. Radiation-induced valvular heart disease. Heart. 2016;102(4):269\u201376.","journal-title":"Heart"},{"key":"2351_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2019.107176","volume":"45","author":"JW van Rijswijk","year":"2020","unstructured":"van Rijswijk JW, Farag ES, Bouten CVC, de Boer OJ, van der Wal A, de Mol B, et al. Fibrotic aortic valve disease after radiotherapy: an immunohistochemical study in breast cancer and lymphoma patients. Cardiovasc Pathol. 2020;45:107176.","journal-title":"Cardiovasc Pathol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02351-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:12:34Z","timestamp":1781637154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02351-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02351-x","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No animal or human subjects by the authors were used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"30"}}